Vpl Diagnostic & Research Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.12 M
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 18.89%
- Profit Growth 64.02%
- Ebitda 49.07%
- Net Worth 44.01%
- Total Assets 47.18%
About Vpl Diagnostic & Research
Vpl Diagnostic & Research Private Limited (VDRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 June 2011 and has a history of 13 years and seven months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Birsingh Chaudhari, Ashish Shrimal, and Unmil Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85110GJ2011PTC066013
- Company No.
066013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2011
- Date of AGM
01 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Vpl Diagnostic & Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Shrimal  | Director | 06-Oct-2023 | Current |
| Birsingh Chaudhari | Director | 06-Oct-2023 | Current |
| Unmil Shah | Director | 21-Jun-2011 | Current |
Financial Performance of Vpl Diagnostic & Research.
Vpl Diagnostic & Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.89% increase. The company also saw a substantial improvement in profitability, with a 64.02% increase in profit. The company's net worth Soared by an impressive increase of 44.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vpl Diagnostic & Research?
In 2023, Vpl Diagnostic & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vpl Diagnostic & Research?
Vpl Diagnostic & Research has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vpl Diagnostic & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vpl Diagnostic & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
